Keywords
Atopic dermatitis; Cajanus cajan (L.) Millsp., methicillin-resistant staphylococcus aureus (MRSA); Anti-inflammatory
Abstract
Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent bacterial infections that cause pruritus, erythema, xerosis and thickening. Cajanus cajan root extract prepared with 95% ethanol (EECR95) has been shown to possess antioxidant, anti-inflammatory, and antibacterial properties in previous studies. This study aimed to evaluate EECR95’s ability to improve AD by inhibiting methicillin-resistant Staphylococcus aureus (MRSA) growth and reducing inflammation. This study found EECR95 effectively inhibits MRSA growth (IC50 = 103.74 μg/mL) and reduces pro-inflammatory cytokine production in an MRSA-keratinocyte-macrophage model. LC/MS/MS analysis revealed the presence of active compounds- flavonoids, isoflavones, and flavonoid glycosides, highlighting EECR95's potential in improving atopic dermatitis in vitro.
Recommended Citation
Yang, Shu-Er; Cai, Xiang-Ming; Chu, Yu-Wen; Tsai, Jen-Chieh; Lee, Mey-Fann; and Song, Tuzz-Ying
(2026)
"Evaluating the Potential of Cajanus cajan (L.) Millsp. Root to Improve Atopic Dermatitis with Different Anti-inflammatory Models and Active Compounds,"
Journal of Food and Drug Analysis: Vol. 34
:
Iss.
3
, Article 12.
Available at: https://doi.org/10.38212/2224-6614.3591
Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Food Science Commons, Medicinal Chemistry and Pharmaceutics Commons, Pharmacology Commons, Toxicology Commons
Abstract Image